Related Experiment Video
Updated: Jul 4, 2026

Rapid Detection of Fecal Antigen of Helicobacter pylori Infection Based on Double Antibody Sandwich Detection Technology
Published on: May 23, 2025
Helicobacter pylori antigen in stool is associated with SIDS and sudden infant deaths due to infectious disease
Arne Stray-Pedersen1, Ashild Vege, Torleiv O Rognum
1Institute of Forensic Medicine, University of Oslo, N-0027 Oslo, Norway. arne.stray-pedersen@medisin.uio.no
Insights
Helicobacter pylori infection is linked to Sudden Infant Death Syndrome (SIDS). This study found H. pylori antigen in SIDS cases, suggesting it may be a triggering pathogen in infant deaths.
Area of Science:
- Pediatrics
- Infectious Diseases
- Gastroenterology
Background:
- Sudden Infant Death Syndrome (SIDS) remains a leading cause of post-neonatal mortality.
- The role of infectious agents, including Helicobacter pylori, in SIDS etiology is debated.
- Understanding potential pathogens is crucial for SIDS prevention strategies.
Purpose of the Study:
- To investigate the association between Helicobacter pylori infection and Sudden Infant Death Syndrome (SIDS).
- To determine the frequency of H. pylori antigen detection in SIDS cases compared to controls.
- To explore the potential role of H. pylori as a triggering pathogen in infant deaths.
Main Methods:
- Utilized the Helicobacter pylori stool antigen (HpSA) immunoassay to test infant deaths and live controls.
- Included histological examination of gastric tissue in a subset of cases.
- Measured IL-6 levels in cerebrospinal fluid to assess central immune response.
Main Results:
- H. pylori antigen was detected significantly more often in SIDS cases (25%) than in live controls (8%).
- In infants aged 1-5 months, HpSA positivity was 31% in SIDS cases versus 1.5% in controls.
- Elevated IL-6 levels were observed in HpSA-positive SIDS victims, indicating immune stimulation.
Conclusions:
- Detection of H. pylori stool antigen is significantly associated with SIDS and infection-related deaths.
- The findings support the hypothesis that H. pylori infection may act as a triggering pathogen in SIDS.
- Further research is warranted to elucidate the precise mechanisms linking H. pylori to sudden infant death.
Abstract:
Infection with Helicobacter pylori has been proposed to be a common cause of Sudden Infant Death Syndrome (SIDS). We investigated the frequency of H. pylori infection in 160 infant deaths and 156 live controls by means of the Helicobacter pylori stool antigen (HpSA) immunoassay. Histology was performed in 26 randomly selected cases. H. pylori antigen was detected in 8% (12/156) of the live controls compared with 25% (30/122) of SIDS cases (p < 0.001), 53% (9/17) of deaths due to infection (p < 0.001), and 9% (1/11) of accidental/violent deaths (p = 0.60). In the classic age peak for SIDS, 1-5 mo, 31% (21/67) of SIDS cases were HpSA positive compared with 1.5% (1/68) of live controls (p < 0.001). Rod-like immunoperoxidase positive H. pylori organisms were identified in 7/12 HpSA positive gastric antrum sections compared with 2/14 HpSA negative (p = 0.038). Significantly elevated IL-6 levels in cerebrospinal fluid representing signs of central immune stimulation were demonstrated in HpSA positive SIDS victims compared with HpSA negative victims (p = 0.045). Detection of H. pylori antigen in stool is associated with SIDS and deaths due to infections. We hypothesize that H. pylori infection in infancy may be involved as the triggering pathogen for sudden death during the first 5 month after birth.
More Related Videos
Related Concept Videos
Peptic Ulcer
Gastritis II: Pathophysiology
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Bacterial Gastroenteritis
Peptic Ulcer Disease II: Pathophysiology
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

